ロード中...
EZH2 activates CHK1 signaling to promote ovarian cancer chemoresistance by maintaining the properties of cancer stem cells
Background: Ovarian cancer is a fatal malignant gynecological tumor. Ovarian cancer stem cells (OCSCs) contribute to resistance to chemotherapy. The polycomb group protein enhancer of zeste homolog 2 (EZH2) plays a key role in maintaining CSCs. Here, we aimed to investigate the specific mechanism by...
保存先:
| 出版年: | Theranostics |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Ivyspring International Publisher
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7778604/ https://ncbi.nlm.nih.gov/pubmed/33408782 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.48101 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|